Compound Detail
CHEMBL19215
METERGOLINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL19215 |
| Name | METERGOLINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | WZHJKEUHNJHDLS-QTGUNEKASA-N |
| Therapeutic | ✓ Yes |
35
Targets
82
Activities
3
Assay Types
1
PK Parameters
20
Publications
7
Known Names
Molecular Properties
403.5
MW (Da)
4.06
ALogP
4
HBA
1
HBD
46.5
PSA (Ų)
0.71
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
ATC Classification
G02CB05
metergoline
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: OTHER GYNECOLOGICALS
Activity Summary
IC50 39 meas. best 9.4
Ki 38 meas. best 9.95
EC50 5 meas. best 8.12
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 9.95 | 9.95 | 0.1 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 9.55 | 9.55 | 0.3 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 9.52 | 9.26 | 0.3 | 2 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 9.46 | 9.38 | 0.3 | 2 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 9.4 | 9.4 | 0.4 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 9.36 | 9.36 | 0.4 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 9.18 | 9.18 | 0.7 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 8.64 | 8.265 | 2.3 | 2 |
| D(3) dopamine receptor CHEMBL234 | Ki | 8.58 | 8.58 | 2.6 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 8.45 | 8.335 | 3.5 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | IC50 | 8.39 | 8.39 | 4.1 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 8.21 | 8.21 | 6.2 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3223 | Ki | 8.2 | 8.2 | 6.3 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 8.2 | 8.2 | 6.3 | 3 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 8.12 | 8.12 | 7.5 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | EC50 | 8.12 | 8.12 | 7.5 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 8.11 | 8.11 | 7.7 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | Ki | 7.96 | 7.78 | 11.0 | 2 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 7.89 | 7.89 | 13.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 7.8 | 7.8 | 16.0 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Serotonin 1 (5-HT1) receptor CHEMBL2095159 | Ki | 7.7 | 7.7 | 20.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 7.68 | 7.68 | 21.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 7.66 | 7.66 | 22.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 7.57 | 7.57 | 27.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 7.55 | 7.55 | 28.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 7.43 | 7.43 | 37.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 7.42 | 7.42 | 38.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | Ki | 7.3 | 7.3 | 50.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 7.24 | 7.24 | 58.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 7.2 | 7.2 | 63.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 7.2 | 7.2 | 63.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 7.17 | 7.17 | 67.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | IC50 | 7.13 | 7.13 | 74.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 7.02 | 7.02 | 95.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 6.87 | 6.87 | 136.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 6.84 | 6.84 | 145.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 6.72 | 6.72 | 189.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.62 | 6.305 | 238.0 | 4 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 6.58 | 6.58 | 262.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.57 | 6.2375 | 268.0 | 4 |
| 5-hydroxytryptamine receptor 4 CHEMBL5017 | Ki | 6.56 | 6.56 | 274.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 6.5 | 6.5 | 313.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 6.44 | 6.44 | 363.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 6.44 | 6.44 | 366.0 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 6.32 | 6.32 | 480.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 6.23 | 6.23 | 590.0 | 1 |
| Histamine H2 receptor CHEMBL1941 | Ki | 6.02 | 6.02 | 959.0 | 1 |
| Histamine H2 receptor CHEMBL1941 | IC50 | 6.01 | 6.01 | 975.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 23.0 | % | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 7 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 23415087 | 10.1016/j.bmc.2013.01.033 | Heparanase | 3 |
| 23403082 | 10.1016/j.bmcl.2013.01.025 | 5-hydroxytryptamine receptor 1A | 3 |
| 3543362 | 10.1021/jm00384a001 | Serotonin 2 (5-HT2) receptor | 3 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Sodium-dependent serotonin transporter | 2 |
| 17417631 | 10.1038/nchembio873 | NON-PROTEIN TARGET | 2 |
| 17417631 | 10.1038/nchembio873 | Unchecked | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| - | 10.1039/C3MD00310H | Plasmodium falciparum | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 12438524 | 10.1124/jpet.102.039255 | ATP-dependent translocase ABCB1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 20451398 | 10.1016/j.bmc.2010.04.039 | ADMET | 2 |
| 39037114 | 10.1021/acs.jmedchem.4c00861 | Sodium channel protein type 2 subunit alpha | 1 |
| 3543362 | 10.1021/jm00384a001 | 5-hydroxytryptamine receptor 1B | 1 |
Data from ChEMBL 36 via Core Engine